Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab

被引:88
作者
Weller, Karsten [1 ]
Ohanyan, Tatevik [1 ]
Hawro, Tomasz [1 ]
Ellrich, Andre [1 ]
Sussman, Gordon [2 ]
Koplowitz, Jake [2 ]
Gimenez-Arnau, Ana M. [3 ]
Peveling-Oberhag, Adriane [4 ]
Staubach, Petra [4 ]
Metz, Martin [1 ]
Maurer, Marcus [1 ]
机构
[1] Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergie Ctr Charite, Berlin, Germany
[2] Univ Toronto, St Michaels Hosp, Div Allergy & Clin Immunol, Toronto, ON, Canada
[3] Univ Autonoma Barcelona, IMIM, Hosp del Mar, Dept Dermatol, Barcelona, Spain
[4] Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany
关键词
D O I
10.1111/all.13586
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2406 / 2408
页数:3
相关论文
共 11 条
[1]   IgE Mediated Autoallergy against Thyroid Peroxidase - A Novel Pathomechanism of Chronic Spontaneous Urticaria? [J].
Altrichter, Sabine ;
Peter, Hans-Juergen ;
Pisarevskaja, Dina ;
Metz, Martin ;
Martus, Peter ;
Maurer, Marcus .
PLOS ONE, 2011, 6 (04)
[2]   Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy [J].
Deza, Gustavo ;
Bertolin-Colilla, Marta ;
Pujol, Ramon M. ;
Curto-Barredo, Laia ;
Soto, Dulce ;
Garcia, Maribel ;
Hernandez, Pilar ;
Gimeno, Ramon ;
Gimenez-Arnau, Ana M. .
ACTA DERMATO-VENEREOLOGICA, 2017, 97 (06) :698-704
[3]   The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change [J].
Ertas, R. ;
Ozyurt, K. ;
Atasoy, M. ;
Hawro, T. ;
Maurer, M. .
ALLERGY, 2018, 73 (03) :705-712
[4]   Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria [J].
Gericke, Janine ;
Metz, Martin ;
Ohanyan, Tatevik ;
Weller, Karsten ;
Altrichter, Sabine ;
Skov, Per Stahl ;
Falkencrone, Sidsel ;
Brand, Janko ;
Kromminga, Arno ;
Hawro, Tomasz ;
Church, Martin K. ;
Maurer, Marcus .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (03) :1059-1061
[5]   Autoimmune chronic spontaneous urticaria: What we know and what we do not know [J].
Kolkhir, Pavel ;
Church, Martin K. ;
Weller, Karsten ;
Metz, Martin ;
Schmetzer, Oliver ;
Maurer, Marcus .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (06) :1772-+
[6]   Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence [J].
Maurer, M. ;
Metz, M. ;
Bindslev-Jensen, C. ;
Bousquet, J. ;
Canonica, G. W. ;
Church, M. K. ;
Godse, K. V. ;
Grattan, C. E. ;
Hide, M. ;
Kocaturk, E. ;
Magerl, M. ;
Makris, M. ;
Meshkova, R. ;
Saini, S. S. ;
Sussman, G. ;
Toubi, E. ;
Zhao, Z. ;
Zuberbier, T. ;
Gimenez-Arnau, A. .
ALLERGY, 2016, 71 (08) :1210-1218
[7]   Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin [J].
Metz, Martin ;
Staubach, Petra ;
Bauer, Andrea ;
Brehler, Randolf ;
Gericke, Janine ;
Kangas, Michael ;
Ashton-Chess, Joanna ;
Jarvis, Philip ;
Georgiou, Panayiotis ;
Canvin, Janice ;
Hillenbrand, Rainer ;
Erpenbeck, Veit J. ;
Maurer, Marcus .
THERANOSTICS, 2017, 7 (05) :1266-1276
[8]   Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis [J].
Metz, Martin ;
Ohanyan, Tatevik ;
Church, Martin K. ;
Maurer, Marcus .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 73 (01) :57-62
[9]   Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria [J].
Palacios, Thamiris ;
Stillman, Leland ;
Borish, Larry ;
Lawrence, Monica .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (03) :529-530
[10]   Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria [J].
Straesser, Matthew D. ;
Oliver, Eric ;
Palacios, Thamiris ;
Kyin, Timothy ;
Patrie, James ;
Borish, Larry ;
Saini, Sarbjit S. ;
Lawrence, Monica G. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (04) :1386-+